title: Hyperparathyroidism secondary to zoledronic acid infusion: case report.
authors.forename: Meral
authors.initials: M
authors.lastname: Sayin
authors.forename: Gozde
authors.initials: G
authors.lastname: Yazici
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced*; D007093:Imidazoles / Q000009:adverse effects*; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid